SCHEMBL167254

SCHEMBL167254

Cc1ccc(C(=O)C(=O)c2ccc(C)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 7/20 1.00
CES1 P23141 7/20 1.00
ALDH1A1 P00352 5/20 0.68
LMNA P02545 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.65
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
PKM P14618 2/20 0.59
HTT P42858 2/20 0.59
ATM Q13315 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
HPGD P15428 1/20 0.59
NLRP1 Q9C000 1/20 0.59
GAA P10253 1/20 0.59
MEN1 O00255 1/20 0.59
NTSR1 P30989 1/20 0.59
KMT2A Q03164 1/20 0.59
SRD5A2 P31213 1/20 0.56
HDAC1 Q13547 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9420272 0.92 CES2 (0.84) CES2CES1ALDH1A1LMNASMN1; SMN2
Butane SCHEMBL9788918 0.89 CES2 (0.80) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL2157002 0.89 CES2 (1.00) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL12695690 0.89 CES2 (0.80) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL6047416 0.88 CES2 (0.79) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL2156105 0.87 CES2 (1.00) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL15679982 0.87 CES2 (0.76) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL14230485 0.87 CES2 (0.76) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL5388314 0.87 CES2 (0.76) CES2CES1ALDH1A1LMNASMN1; SMN2
SCHEMBL1104323 0.86 CES2 (0.75) CES2CES1ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132314-A1 ADHESIVE TAPE ETERNAL MATERIALS CO., LTD. (TW) 2026-05-14 US claimed
EP-4455168-B1 VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD CHT TURKEY KIMYA SANAYI VE TICARET A S (TR) 2025-12-24 EP claimed
EP-4633900-A1 SACRIFICIAL ADDITIVELY MANUFACTURED MOLD WITH CONTROLLED MOISTURE AND LIQUID ABSORPTION PROPERTIES STRATASYS, INC. (US) 2025-10-22 EP claimed
EP-4606840-A2 ISOCYANATE-FREE POLYURETHANE AND ISOCYANATE-FREE POLYURETHANE-CONTAINING POLYMERIC FILM PRODUCTION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2025-08-27 EP claimed
WO-2025106936-A1 POLY(METH)ACRYLIMIDE MATERIALS WITH ENHANCED THERMOMECHANICAL PROPERTIES GENCORES, INC. (US) 2025-05-22 WO claimed
US-12286558-B2 UV-curable anti-smudge and anti-graffiti compositions QUEEN'S UNIVERSITY AT KINGSTON (CA) 2025-04-29 US claimed
WO-2025014975-A2 LUBRICIOUS COATINGS FOR SKIS AND SNOWBOARDS AND RELATED SYSTEMS AND METHODS OF USE Drake Holdings, Inc. (US) 2025-01-16 WO claimed
EP-4455168-A1 VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2024-10-30 EP claimed
EP-4428168-A1 POLYURETHANE/OLIGOMERIC URETHANE SYNTHESIS METHOD BY RADIATION CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2024-09-11 EP claimed
EP-4428180-A1 ISOCYANATE-FREE POLYURETHANE AND ISOCYANATE-FREE POLYURETHANE-CONTAINING POLYMERIC FILM PRODUCTION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2024-09-11 EP claimed
WO-2007134219-A2 IN SITU POLYMERIZATION FOR SKIN TREATMENT LIVING PROOF, INC. (US) 2007-11-22 WO claimed
WO-2007127065-A2 IN SITU POLYMERIZATION FOR HAIR TREATMENT LIVING PROOF, INC. (US) 2007-11-08 WO claimed
EP-1300132-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 EP claimed
EP-0409437-B1 Process for preparing aromatic polycarboxylic acids KUREHA CHEMICAL IND CO LTD (JP) 1994-09-21 EP claimed
EP-0197616-B1 PHOTOPOLYMERIZABLE COMPOSITION AND A PHOTO-INITIATOR SYSTEM DSM RESINS B.V. (NL) 1992-08-12 EP claimed
US-5087742-A Catalytic oxidation of benzil derivative KUREHA KAGAKU KOGYO K.K. (JP) 1992-02-11 US claimed
EP-0409437-A2 Process for preparing aromatic polycarboxylic acids KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1991-01-23 EP claimed
EP-0197616-A1 Photopolymerizable composition and a photo-initiator system DSM RESINS B.V. (NL) 1986-10-15 EP claimed
EP-0185423-A1 Photopolymerizable composition and a photo-initiator system DSM RESINS B.V. (NL) 1986-06-25 EP claimed
US-4208005-A Method for mounting parts on circuit boards HITACHI, LTD. (JP) 1980-06-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132314-A1 ADHESIVE TAPE GGH, ALKBH3, OGDH CES2 2748/4885CES1 3154/4885ALDH1A1 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.